(Q40580530)

reason for preferred rank

21 September 2017

Acute lymphoblastic leukemia.The significance of nuclear convolutions (English)

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

21 February 2023

Acute lymphoblastic leukemia: the significance of nuclear convolutions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A283876

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

21 February 2023

main subject

lymphoblastic leukemia

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

21 February 2023

author name string

G. A. Pangalis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A283876

21 February 2023

B. N. Nathwani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A283876

21 February 2023

H. Rappaport

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A283876

21 February 2023

R. B. Rosen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A283876

21 February 2023

language of work or name

English

0 references

publication date

1 February 1979

1 reference

full work available at URL

21 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

21 February 2023

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

21 February 2023

1 reference

21 September 2017

43

1 reference

21 September 2017

2

1 reference

21 September 2017

551-557

1 reference

A study of childhood non-hodgkin's lymphoma

21 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197902%2943%3A2%3C551%3A%3AAID-CNCR2820430222%3E3.0.CO%3B2-U

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

3

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

T- and b-lymphocytes and lymphoblasts in untreated acute lymphocytic leukemia

21 February 2023

7

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

T-lymphoblastic Leukaemia: A Distinct Variant of Acute Leukaemia

21 February 2023

8

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

21 February 2023

Cancer Treatment Reports

12

61

945

Dorfman

1977

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

21 February 2023

14

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

21 February 2023

15

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Acute leukaemia 1959-64: factors affecting prognosis

21 February 2023

16

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Nonparametric Estimation from Incomplete Observations

21 February 2023

17

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology

21 February 2023

18

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Treatment of acute leukemia

21 February 2023

19

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Interrupted vs. continued maintenance therapy in childhood acute leukemia

21 February 2023

23

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Immunologic characterization of human malignant lymphomas

21 February 2023

24

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Lack of correlation of lymphoblast cell size with presence of T-cell markers or with outcome in childhood acute lymphoblastic leukaemia

21 February 2023

26

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Malignant lymphoma, lymphoblastic

21 February 2023

28

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Non-hodgkin's lymphomas.A clinicopathologic study comparing two classifications

21 February 2023

29

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Morphological Criteria for Prognostication of Acute Lymphoblastic Leukaemia

21 February 2023

31

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Epidemiological factors and survival experience in 1770 children with acute leukemia. Treated by members of Children's Study Group A between 1957 and 1964

21 February 2023

32

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Survivals of 5 to 15 years in acute leukemiaa study of 21 children

21 February 2023

36

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Clinical importance of lymphoblasts with T markers in childhood acute leukemia

21 February 2023

37

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Initial features and prognosis in 363 children with acute lymphocytic leukemia

21 February 2023

38

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Lymphoblastic lymphoma of convoluted or acid phosphatase type-A tumor of T precursor cells

21 February 2023

39

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

21 February 2023

Treatment of lymphoma

40

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Long survivals in acute leukaemia

21 February 2023

41

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Surface Markers and Prognostic Factors in Acute Lymphoblastic Leukemia

21 February 2023

42

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

Poor prognosis in negro children with acute lymphocytic leukemia

21 February 2023

43

1 reference

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C551::AID-CNCR2820430222%3E3.0.CO;2-U

21 February 2023

Identifiers

10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U

1 reference

21 September 2017

1 reference